Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

DiscoveryBioMed receives grant for ADPKD drug development

Oct. 8, 2014

Linagliptin as potential treatment for uremic calcification

Oct. 3, 2014

Dimerix Bioscience receives approval to begin phase II trial of DMX-200

Oct. 2, 2014

CB2 agonists show potential for the treatment of kidney disease

Sep. 9, 2014

FDA approves Keryx Biopharmaceuticals' ferric citrate

Sep. 8, 2014

Tricida confirms new clinical candidate for cardiorenal disease

Sep. 8, 2014

Velphoro receives marketing authorization in Europe

Aug. 28, 2014

La Jolla Pharmaceutical initiates phase I/II trial of LJPC-501 in hepatorenal syndrome

Aug. 26, 2014

Mitsubishi Tanabe Pharma and AstraZeneca form diabetic nephropathy collaboration

Aug. 21, 2014

Allergan acquires lidocaine for interstitial cystitis/bladder pain syndrome

Aug. 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...